palladium has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista de Carvalho, AL; Costa, FM; Diniz, C; Marques, MP; Medeiros, PS; Ribeiro, VP; Sousa, JB | 1 |
Chin, KJ; Finger, PT | 1 |
Guo, H; Li, Y; Xu, T; Yang, H | 1 |
3 other study(ies) available for palladium and Angiogenesis, Pathologic
Article | Year |
---|---|
Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent.
Topics: Animals; Avian Proteins; Breast Neoplasms; Cell Movement; Cell Proliferation; Chick Embryo; Chickens; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Neovascularization, Pathologic; Palladium; Spermine; Taxoids; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brachytherapy; Choroid Neoplasms; Eye Hemorrhage; Female; Humans; Intravitreal Injections; Male; Middle Aged; Neovascularization, Pathologic; Optic Nerve Diseases; Palladium; Papilledema; Prospective Studies; Radiation Injuries; Radioisotopes; Visual Acuity | 2012 |
Is phosphorescence lifetime an indicator of angiogenesis in cortical sarcoma?
Topics: Animals; Factor VIII; Immunohistochemistry; Luminescent Measurements; Mesoporphyrins; Metalloporphyrins; Mice; Microcirculation; Neovascularization, Pathologic; Oxygen Consumption; Palladium; Sarcoma 180 | 2007 |